At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
In Brief
A clinical study evaluating EMPOWER-ED for Taking Benzodiazepines for Any Reason for 3 Months and Benzodiazepine Dependence. Completed, enrolled 170 participants across 1 site.
Detailed Summary
Benzodiazepines (e.g., Ativan, Xanax) are widely prescribed medications that are used mainly to treat anxiety and sleeping difficulties. Long-term use of benzodiazepine carries risks of physical dependence, addiction, falls and other accidents, and problems in thinking/concentrating. Researchers in Canada developed a printed self-help packet that enabled many individuals to reduce or cease taking benzodiazepines on their own. This study is designed to tailor that packet to the Veteran population, convert it to an app that people can use on their laptop or smart phone, and test whether the app helps promote benzodiazepine prescribing.
Study Details
Timeline
Interventions
An electronic app that runs on a variety of platforms and provides education and tools designed to promote self-driven reduction of benzodiazepines.